𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Fas concentrations in the serum and liver tissue in chronic hepatitis B patients treated with lamivudine

✍ Scribed by T.W. Lapinski; A. Panasiuk; D. Prokopowicz

Book ID
117372668
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
157 KB
Volume
38
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Loss of hepatitis B surface antigen from
Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine
✍ Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Tetsuya Hosaka; Hitomi Sezaki; H πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 174 KB πŸ‘ 1 views

## Abstract Although loss of hepatitis B e antigen (HBeAg) from the serum is sought by treatment with lamivudine, clearance of hepatitis B surface antigen (HBsAg) is the eventual goal of any antiviral therapy. In a single hepatology center in the Metropolitan Tokyo, 486 patients with chronic hepati

Variations in the serum concentrations o
Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus
✍ Le H. Song; Vu Q. Binh; Dinh N. Duy; Thomas C. Bock; Peter G. Kremsner; Adrian J πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract Earlier studies of both chronic hepatitis B and C virus (HBV and HCV) patients have shown a strong correlation between the soluble membrane Fas (sFas) and Fas protein expression on hepatocytes. The serum concentrations of sFas and soluble Fas ligand (sFasL) was examined in both healthy